{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:03:43Z","timestamp":1772809423797,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.yrtph.2008.08.004","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T11:52:50Z","timestamp":1219319570000},"page":"264-289","source":"Crossref","is-referenced-by-count":37,"title":["Evidence-based dose\u2013response assessment for thyroid tumorigenesis from acrylamide"],"prefix":"10.1016","volume":"52","author":[{"given":"Michael","family":"Dourson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hertzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Kroner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Kohrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2008.08.004_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1383-5718(02)00322-4","article-title":"The dose\u2013response relationship at very low doses of acrylamide is linear in the flow cytometer-based mouse micronucleus assay","volume":"535","author":"Abramsson-Zetterberg","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0165-1218(88)90124-3","article-title":"Clastogenic effects of acrylamide in mouse bone marrow cells","volume":"206","author":"Adler","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1289\/ehp.93101s35","article-title":"Development of screening tests for aneuploidy induction by environmental pollutants","volume":"101","author":"Adler","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2008.08.004_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00317980","article-title":"Effect of acrylamide on neurotransmitter metabolism and neuropeptide levels in several brain regions and upon circulating hormones","volume":"52","author":"Ali","year":"1983","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1539-6924.1988.tb01193.x","article-title":"Correlation between carcinogenic potency of chemicals in animals and humans","volume":"8","author":"Allen","year":"1988","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2008.08.004_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yrtph.2004.09.006","article-title":"Dose\u2013response modeling of in vivo genotoxicity data for use in risk assessment: some approaches illustrated by an analysis of acrylamide","volume":"41","author":"Allen","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/em.2850130305","article-title":"The effects of acrylamide on mouse germ-line and somatic cell chromosomes","volume":"13","author":"Backer","year":"1989","journal-title":"Environ. Mol. Mutagen"},{"issue":"3","key":"10.1016\/j.yrtph.2008.08.004_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/carcin\/bgm006","article-title":"A review of mechanisms of acrylamide carcinogenicity","volume":"28","author":"Besaratinia","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yrtph.2008.08.004_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0091-3057(81)90313-0","article-title":"Neurotransmitter receptors in brain regions of acrylamide-treated rats II. Effects of extended exposure to acrylamide","volume":"14","author":"Bondy","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.yrtph.2008.08.004_bib1a","series-title":"Endocrine System","first-page":"176","article-title":"Follicular cell hyperplasia, thyroid, rat","author":"Boorman","year":"1983"},{"key":"10.1016\/j.yrtph.2008.08.004_bib116","doi-asserted-by":"crossref","unstructured":"Bowyer, J.F., Latendresse, J.R., Delongchamp, R.R., Muskhelishvili, L., Warbritton, A.R., Thomas, M., Tareke, E., McDaniel, L.P., Doerge, D.R., 2008. The effects of subchronic acrylamide exposure on gene expression, neurochemistry, hormones, and histopathology in the hypothalamus-pituitary-thyroid axis of male Fischer 344 rats. Toxicol. Appl. Pharmacol., doi:10.1016\/j.taap.2008.02.029.","DOI":"10.1016\/j.taap.2008.02.029"},{"key":"10.1016\/j.yrtph.2008.08.004_bib10","first-page":"157","article-title":"Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery","volume":"4","author":"Burek","year":"1980","journal-title":"J. Environ. Pathol. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib11","unstructured":"Burnam, W., 2007. Personal communication with Michael Dourson. Toxicology Excellence for Risk Assessment (TERA). Cincinnati, OH. October."},{"key":"10.1016\/j.yrtph.2008.08.004_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yrtph.2006.01.011","article-title":"A classification framework and practical guidance for establishing a mode of action for chemical carcinogens","volume":"45","author":"Butterworth","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/rtph.1998.1273","article-title":"A comprehensive approach for integration of toxicity and cancer risk assessments","volume":"29","author":"Butterworth","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/em.2850200303","article-title":"Tissue-specific genotoxic effects of acrylamide and acrylonitrile","volume":"20","author":"Butterworth","year":"1992","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.yrtph.2008.08.004_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1289\/ehp.9399221","article-title":"A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide","volume":"99","author":"Calleman","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2008.08.004_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0378-4274(92)90211-2","article-title":"Pathophysiology of chemical injury of the thyroid gland","volume":"64","author":"Capen","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2008.08.004_bib17","series-title":"Werner and Ingbar\u2019s The Thyroid: A Fundamental and Clinical Text","first-page":"19","article-title":"Chapter 3: anatomy","author":"Capen","year":"1996"},{"key":"10.1016\/j.yrtph.2008.08.004_bib18","unstructured":"Capen, C.C., 2001. Toxic Responses of the Endocrine System. Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons, sixth ed. 730 (Chapter 21)."},{"key":"10.1016\/j.yrtph.2008.08.004_bib19","first-page":"144","article-title":"Genotoxicity and carcinogenicity of acrylamide: A critical review","volume":"42","author":"Carere","year":"2006","journal-title":"Ann 1st Super Sanita"},{"key":"10.1016\/j.yrtph.2008.08.004_bib20","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/S0021-9258(18)93315-6","article-title":"Specific modification of protein sulfhydryl groups with \u03b1, \u03b2-unsaturated compounds","volume":"243","author":"Cavins","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yrtph.2008.08.004_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mce.2006.06.003","article-title":"Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures","volume":"257\u2013258","author":"Chico Galdo","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-7992(88)90117-0","article-title":"Cytogenetic effects of acrylamide in the bone marrow of mice","volume":"209","author":"Cihak","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/toxsci\/kfh223","article-title":"Human respiratory tract cancer risks of inhaled formaldehyde: dose\u2013response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset","volume":"82","author":"Conolly","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2008.08.004_bib24","unstructured":"CIR (Cosmetic Ingredient Review) Panel. 2005. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics. Int. J. Toxicol. 24(2), 21\u201350."},{"key":"10.1016\/j.yrtph.2008.08.004_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-1110(88)90015-2","article-title":"Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity","volume":"195","author":"Dearfield","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0027-5107(95)00037-J","article-title":"Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk","volume":"330","author":"Dearfield","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/taap.1999.8670","article-title":"Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations","volume":"158","author":"DeJongh","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0013-9351(81)90195-X","article-title":"Effect of acrylamide on biogenic amine levels, monamine oxidase, and cathepsin D activity of rat brain","volume":"26","author":"Dixit","year":"1981","journal-title":"Environ. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mrgentox.2004.10.013","article-title":"DNA adducts derived from administration of acrylamide and glycidamide to mice and rats","volume":"580","author":"Doerge","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib30","unstructured":"Dulak, L.H., 1989. A lifetime oncogenicity study in rats with acrylamide. American Cyanamid Company. Performed by: Tegeris Laboratories and Pathology Associates, Inc., Study No. 85033."},{"key":"10.1016\/j.yrtph.2008.08.004_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/toxsci\/kfg165","article-title":"Risk assessment of acrylamide in foods","volume":"75","author":"Dybing","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2008.08.004_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.fct.2004.11.004","article-title":"Human exposure and internal dose assessments of acrylamide in food","volume":"43","author":"Dybing","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib33","unstructured":"European Union. 2002. Risk Assessment Report. Acrylamide. European Chemicals Bureau, Institute for Health and Consumer Protection."},{"key":"10.1016\/j.yrtph.2008.08.004_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/10937400600681430","article-title":"A review of the toxicology of acrylamide","volume":"9","author":"Exon","year":"2006","journal-title":"J. Toxicol. Environ. Health, Part B"},{"key":"10.1016\/j.yrtph.2008.08.004_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/toxsci\/kfi069","article-title":"Metabolism and hemoglobin adduct formation of acrylamide in humans","volume":"85","author":"Fennel","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2008.08.004_bib36","unstructured":"FAO (Food and Agriculture Organization). 2006. Safety evaluation of certain contaminants in food. WHO Food Additives Series. 55, 1\u2013157."},{"key":"10.1016\/j.yrtph.2008.08.004_bib37","article-title":"Effects of acrylamide on rat hormone levels in a 28-day drinking water study","author":"Friedman","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/faat.1995.1112","article-title":"A lifetime oncogenicity study in rats with acrylamide","volume":"27","author":"Friedman","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2008.08.004_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1055-9965.EPI-05-0647","article-title":"Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity","volume":"15","author":"Fuhr","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.yrtph.2008.08.004_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mrfmmm.2005.05.004","article-title":"Absence of acrylamide-induced genotoxicity in CYP2E1-null mice. Evidence consistent with a glycidamide-mediated effect","volume":"578","author":"Ghanayem","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2307\/3431313","article-title":"Predicting the carcinogenicity of chemicals in humans from rodent bioassay data","volume":"94","author":"Goodman","year":"1991","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2008.08.004_bib42","unstructured":"Gorzinski, S.J., Johnson, K.A., Campbell, R.A., Morden, D.C., Tollett, J.T., 1984. Acrylamide: Interim Data from a 2-Year Drinking Water Chronic Toxicity-Oncogenicity Study in Fischer Rats. Draft Report. Mammalian and Environmental Toxicology Research Laboratory, The Dow Chemical Company, Midland, Michigan (as cited in Johnson et al., 1984)."},{"key":"10.1016\/j.yrtph.2008.08.004_bib43","unstructured":"Haber. L. 2007. Personal communication with V. Dellarco of EPA. Society for Risk Ananlysis Annual Meeting. December."},{"key":"10.1016\/j.yrtph.2008.08.004_bib44","unstructured":"Haber, L.H., Maier, A., Kroner, O.L., Kohrman, M.J., submitted for publication. Evaluation of human relevance and mode of action for tunica vaginalis mesotheliomas resulting from oral exposure to acrylamide."},{"key":"10.1016\/j.yrtph.2008.08.004_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10408449891344173","article-title":"Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity","volume":"28","author":"Hakkola","year":"1998","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0272-0590(89)90001-8","article-title":"Thyroid follicular cell carcinogenesis","volume":"12","author":"Hill","year":"1989","journal-title":"Fundam. Appl. Toxicol."},{"issue":"11","key":"10.1016\/j.yrtph.2008.08.004_bib47","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1158\/1055-9965.EPI-07-0581","article-title":"A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer","volume":"16","author":"Hogervorst","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.yrtph.2008.08.004_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/mutage\/8.1.7","article-title":"Detection of chemical mutagens using muta mouse: a transgenic mouse model","volume":"8","author":"Hoorn","year":"1993","journal-title":"Mutagenesis"},{"key":"10.1016\/j.yrtph.2008.08.004_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1289\/ehp.98106437","article-title":"Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents","volume":"106","author":"Hurley","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2008.08.004_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2004.12.019","article-title":"Enhancement by acrylamide of N-methyl-N-nitrosourea-induced rat mammary tumor development-possible application for a model to detect co-modifiers of carcinogenesis","volume":"230","author":"Imai","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yrtph.2008.08.004_bib51","unstructured":"Imai, T., Takami, S., Cho, Y.M., Hirose, M., Nishikawa, A., 2008. A 12-week toxicological study of orally administered acr in juvenile rats. The Toxicologist. Poster 480. Annual Meeting of the Society of Toxicology. Seattle, Washington."},{"key":"10.1016\/j.yrtph.2008.08.004_bib52","unstructured":"IPCS. 2005. Chemical-specific adjustment factors for interspecies differences and human variability: Guidance document for use of data in dose\/concentration\u2013response assessment. Harmonization Project. World Health Organization. International Programme for Chemical Safety. pp. 1\u201396."},{"key":"10.1016\/j.yrtph.2008.08.004_bib53","unstructured":"Johnson, K., Gorzinski, S., Bodner, K., Campbell, R., 1984. Acrylamide: A two-year drinking water chronic toxicity-oncogenicity study in Fischer 344 rats. Dow Chemical. Midland, MI. Unpublished Report."},{"key":"10.1016\/j.yrtph.2008.08.004_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0041-008X(86)90109-2","article-title":"Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats","volume":"85","author":"Johnson","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/jpet.102.053124","article-title":"Human hepatic CYP2E1 expression during development","volume":"307","author":"Johnsrud","year":"2003","journal-title":"J. Pharmacol. Exper. Ther."},{"key":"10.1016\/j.yrtph.2008.08.004_bib56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1539-6924.2005.00649.x","article-title":"An interagency comparison of screening-level risk assessment approaches","volume":"25","author":"Jones-Otazo","year":"2005","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2008.08.004_bib57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s004280050186","article-title":"CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma","volume":"432","author":"Khan","year":"1998","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yrtph.2008.08.004_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/toxsci\/47.2.151","article-title":"Changes in thyroid gland morphology after acute acrylamide exposure","volume":"47","author":"Khan","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2008.08.004_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/15287390306368","article-title":"A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat","volume":"66","author":"Kirman","year":"2003","journal-title":"J. Toxicol. Environ. Health, A"},{"key":"10.1016\/j.yrtph.2008.08.004_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/0-387-24980-X_4","article-title":"Mechanisms of acrylamide induced rodent carcinogenesis","volume":"561","author":"Klaunig","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.yrtph.2008.08.004_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/mutage\/3.3.263","article-title":"Mutagenic activity of acrylamide in eukaryotic systems but not in bacteria","volume":"3","author":"Knapp","year":"1988","journal-title":"Mutagenesis"},{"key":"10.1016\/j.yrtph.2008.08.004_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1539-6924.1993.tb01067.x","article-title":"Upper confidence limits on excess risk for quantitative responses","volume":"13","author":"Kodell","year":"1993","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2008.08.004_bib63","unstructured":"Kopp, E.K., Dekant, W., 2008. Acrylamide: toxicokinetics in humans. The toxicologist. Poster 479. Annual Meeting of the Society of Toxicology. Seattle, Washington."},{"key":"10.1016\/j.yrtph.2008.08.004_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mrgentox.2005.11.006","article-title":"Genotoxicity of acrylamide and glycidamide in human lymphoblastoid TK6 cells","volume":"603","author":"Koyama","year":"2006","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.yrtph.2008.08.004_bib65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/105072503322238836","article-title":"Cold thyroid nodules show a marked increase in proliferation markers","volume":"13","author":"Krohn","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.yrtph.2008.08.004_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.toxlet.2004.07.008","article-title":"Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat","volume":"154","author":"Lafferty","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2008.08.004_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(89)90496-4","article-title":"In vitro binding of [14C] acrylamide to neurofilament and microtubule proteins of rats","volume":"481","author":"Lapadula","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib68","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/carcin\/18.11.2101","article-title":"Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver","volume":"18","author":"Leavitt","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yrtph.2008.08.004_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0161-813X(02)00155-9","article-title":"Acrylamide neuropathy III. Spatiotemporal characteristics of nerve cell damage in forebrain","volume":"25","author":"Lehning","year":"2003","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.yrtph.2008.08.004_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/er.21.1.40","article-title":"Is estradiol a genotoxic mutagenic carcinogen?","volume":"21","author":"Liehr","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.yrtph.2008.08.004_bib71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/15376520490429382","article-title":"Incorporation of pharmacokinetic and pharmacodynamic data into risk assessments","volume":"14","author":"Lipscomb","year":"2004","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.yrtph.2008.08.004_bib72","doi-asserted-by":"crossref","unstructured":"LoPachin, R., Barber, D., He, D., Das, S., 2006. Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles. Toxicol. Sci. 89, 224\u2013234.","DOI":"10.1093\/toxsci\/kfj005"},{"key":"10.1016\/j.yrtph.2008.08.004_bib73","unstructured":"Maier, A., Kohrman, M.J., Hertzberg, R., Allen, B., Haber, L., submitted for publication. Reevaluation of dose\u2013response options for F344 rat mammary tumors for acrylamide\u2014additional insights on mode of action."},{"key":"10.1016\/j.yrtph.2008.08.004_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mrgentox.2004.10.012","article-title":"DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide","volume":"580","author":"Maniere","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib75","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/em.20157","article-title":"Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice","volume":"47","author":"Manjanatha","year":"2006","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.yrtph.2008.08.004_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0378-4274(92)90213-4","article-title":"Thyroid gland neoplasia: non-genotoxic mechanisms","volume":"64","author":"McClain","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2008.08.004_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib78","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/JOM.0b013e31802db536","article-title":"Mortality patterns among workers exposed to acrylamide: updated follow up","volume":"49","author":"Marsh","year":"2007","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.yrtph.2008.08.004_bib1b","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.fct.2007.09.093","article-title":"Genotoxic effects of acrylamide and glycidamide in mouse lymphooma cells","volume":"46","author":"Mei","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/em.2860090305","article-title":"Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells","volume":"9","author":"Moore","year":"1987","journal-title":"Environ. Mutagen"},{"key":"10.1016\/j.yrtph.2008.08.004_bib79","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.bjc.6600726","article-title":"Dietary acrylamide and cancer of the large bowel, kidney and bladder: Absence of an association in a population-based study in Sweden","volume":"88","author":"Mucci","year":"2003","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.yrtph.2008.08.004_bib82","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ijc.20011","article-title":"Dietary acrylamide and risk of renal cell cancer. Short Report","volume":"109","author":"Mucci","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.yrtph.2008.08.004_bib83","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.293.11.1326","article-title":"Acrylamide intake and breast cancer risk in Swedish women","volume":"293","author":"Mucci","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.yrtph.2008.08.004_bib84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ijc.21309","article-title":"Prospective study of dietary acrylamide and risk of colorectal cancer among women","volume":"118","author":"Mucci","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yrtph.2008.08.004_bib85","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/em.2850180420","article-title":"Validation studies with muta mouse: a transgenic mouse model for detecting mutations in vivo","volume":"18","author":"Myhr","year":"1991","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.yrtph.2008.08.004_bib86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-7992(89)90013-4","article-title":"Mutagenic and teratogenic effects of acrylamide in the mammalian spot test","volume":"226","author":"Neuhaeuser-Klaus","year":"1989","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib87","unstructured":"OEHHA. 2005. No Significant Risk Level (NSRL) for the Proposition 65 carcinogen Acrylamide. Sacramento, CA. California Environmental Protection Agency. Office of Environmental Health Hazard Assessment."},{"key":"10.1016\/j.yrtph.2008.08.004_bib88","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/ijc.23359","article-title":"Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish diet, cancer and health study","volume":"122","author":"Olesen","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yrtph.2008.08.004_bib89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/toxsci\/65.2.177","article-title":"Acrylamide-induced cellular transformation","volume":"65","author":"Park","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2008.08.004_bib90","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1383-5718(02)00281-4","article-title":"Induction of micronuclei in mouse and rat by glycidamide, genotoxic metabolite of acrylamide","volume":"535","author":"Paulsson","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib92","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ijc.21336","article-title":"Dietary acrylamide and human cancer","volume":"118","author":"Pelucchi","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yrtph.2008.08.004_bib91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mrgentox.2004.11.009","article-title":"DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells","volume":"580","author":"Puppel","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib93","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0027-5107(94)90101-5","article-title":"Weak genotoxicity of acrylamide on premeiotic and somatic cells of the mouse","volume":"309","author":"Russo","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib94","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/carcin\/16.5.1161","article-title":"Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide","volume":"16","author":"Segerback","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yrtph.2008.08.004_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0300-483X(95)03240-G","article-title":"Chemical mixtures from a public health perspective: the importance of research for informed decision making","volume":"105","author":"Sexton","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2008.08.004_bib96","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10408440600851377","article-title":"Acrylamide: review of toxicity data and dose\u2013response analyses for cancer and noncancer effects","volume":"36","author":"Shipp","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0027-5107(78)90216-6","article-title":"Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice","volume":"57","author":"Shiraishi","year":"1978","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib98","first-page":"3465","article-title":"Direct alkylation of 2\u2032-doxynucleosides and DNA following in vitro reaction with acrylamide","volume":"45","author":"Solomon","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib99","unstructured":"Sorg, R., Naismith, R., Matthews, R., 1982. Genetic toxicity micronucleus test (MNT). Pharmakon. Res. Int. PH 309A-AC-001-82 (as cited in European Union, 2002)."},{"key":"10.1016\/j.yrtph.2008.08.004_bib100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/oem.2006.030130","article-title":"Mortality study update of acrylamide workers","volume":"64","author":"Swaen","year":"2007","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.yrtph.2008.08.004_bib101","unstructured":"Swenberg, J.A., Fryar-Tita, E., Jeong, Y.C., Boysen, G., Starr, T., Walker, V.E., Albertini, R.J., in press. Biomarkers in toxicology and risk assessment: Informing critical dose response assessment relationships. Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2008.08.004_bib102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mrgentox.2003.07.004","article-title":"In vivo transgenic mutation assays","volume":"540","author":"Thybaud","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/mutage\/8.1.23","article-title":"Acrylamide: induction of DNA damage, chromosomal aberrations and cell transformation without gene mutations","volume":"8","author":"Tsuda","year":"1993","journal-title":"Mutagenesis"},{"key":"10.1016\/j.yrtph.2008.08.004_bib104","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1021\/jf0497657","article-title":"Autoclave sterilization produces acrylamide in rodent diets: implications for toxicity testing","volume":"52","author":"Twaddle","year":"2004","journal-title":"J. Agricul. Food Chem."},{"key":"10.1016\/j.yrtph.2008.08.004_bib105","unstructured":"US EPA. 1988. Rat\/Mouse Default Values. Recommendations for and Documentation of Biological Values for Use in Risk Assessment. EPA\/600\/6-87\/008."},{"key":"10.1016\/j.yrtph.2008.08.004_bib106","unstructured":"US EPA. 1998. Assessment of thyroid follicular cell tumors. Risk Assessment Forum. Washington, DC. U.S. Environmental Protection Agency. EPA\/630\/R-97\/002. March."},{"key":"10.1016\/j.yrtph.2008.08.004_bib107","unstructured":"US EPA. 2001. Help manual for benchmark dose software version 1.3. Available from: <http:\/\/cfpub.epa.gov\/ncea\/cfm\/bmds.cfm?ActType=default>."},{"key":"10.1016\/j.yrtph.2008.08.004_bib108","unstructured":"US EPA. 2003. Proposed OPPTS Science Policy: PPAR-mediated Hepatocarcinogenesis in Rodents and Relevance to Human Health Risk Assessments. United States Environmental Protection Agency."},{"key":"10.1016\/j.yrtph.2008.08.004_bib109","unstructured":"US EPA. 2005. Guidelines for carcinogen risk assessment. United States Environmental Protection Agency. EPA\/630\/P-03\/001b."},{"key":"10.1016\/j.yrtph.2008.08.004_bib110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1432-1033.1996.0476z.x","article-title":"Developmental expression of CYP2El in the human liver hypermethylation control of gene expression during the neonatal period","volume":"238","author":"Vieira","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.yrtph.2008.08.004_bib111","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1080\/15287390701601202","article-title":"Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child\u2013adult dosimetry differences","volume":"70","author":"Walker","year":"2007","journal-title":"J. Toxicol. Environ. Health. Part A"},{"issue":"65","key":"10.1016\/j.yrtph.2008.08.004_bib112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0378-4274(92)90210-B","article-title":"Cell proliferation and thyroid neoplasia","volume":"64","author":"Williams","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2008.08.004_bib113","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0027-5107(95)00138-7","article-title":"Mechanisms and pathogenesis of thyroid cancer in animals and man","volume":"333","author":"Williams","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.08.004_bib114","unstructured":"Williams, E., 2008. Personal communication with Ann Parker. Toxicology Excellence for Risk Assessment (TERA). Cincinnati, OH. May."},{"key":"10.1016\/j.yrtph.2008.08.004_bib115","doi-asserted-by":"crossref","unstructured":"Young, J.F., Luecke, R.H., Doerge, D.R., 2007. Physiologically based pharmacokinetic\/pharmacodynamic model for acrylamide and its metabolites in mice, rats, and humans. Amer. Chem. Soc. epublication.","DOI":"10.1021\/tx600287w"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230008001669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230008001669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T17:51:56Z","timestamp":1684518716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230008001669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0273230008001669"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2008.08.004","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}